
As a startup biotechnology company, Granalix is dedicated to advancing the field of healthcare through innovation and cutting-edge research. Founded by two renowned professors, Prof. Ruth Gabizon from the Neurology Department of the Hadassah Medical Center and Prof. Shlomo Magdassi from the Casali Institute of Chemistry of The Hebrew University, Granalix represents the culmination of their combined experience and knowledge. Specializing in the development of biotechnology products, Granalix is committed to producing innovative solutions that address the most pressing healthcare challenges…
Built from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Annual Revenue$10M to $25M
Estimated OwnershipPrivateMatching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.